Greatwall promotes cell transformation by hyperactivating AKT in human malignancies

  1. Jorge Vera
  2. Lydia Lartigue
  3. Suzanne Vigneron
  4. Gilles Gadea
  5. Veronique Gire
  6. Maguy Del Rio
  7. Isabelle Soubeyran
  8. Frederic Chibon
  9. Thierry Lorca
  10. Anna Castro  Is a corresponding author
  1. Université de Montpellier, France
  2. Université Bordeaux Segalen, France
  3. Institut de Recherche en Cancérologie de Montpellier, France

Abstract

The PP2A phosphatase is often inactivated in cancer and is considered as a tumour suppressor. A new pathway controlling PP2A activity in mitosis has been recently described. This pathway includes the Greatwall (GWL) kinase and its substrates endosulfines. At mitotic entry, GWL is activated and phosphorylates endosulfines that then bind and inhibit PP2A. We analysed whether GWL overexpression could participate in cancer development. We show that GWL overexpression promotes cell transformation and increases invasive capacities of cells through hyperphosphorylation of the oncogenic kinase AKT. Interestingly, AKT hyperphosphorylation induced by GWL is independent of endosulfines. Rather, GWL induces GSK3 kinase dephosphorylation in its inhibitory sites and subsequent SCF-dependent degradation of the PHLPP phosphatase responsible for AKT dephosphorylation. In line with its oncogenic activity, we find that GWL is often overexpressed in human colorectal tumoral tissues. Thus, GWL is a human onocoprotein that promotes the hyperactivation of AKT via the degradation of its phosphatase, PHLPP, in human malignancies.

Article and author information

Author details

  1. Jorge Vera

    Centre de Recherche de Biochimie Macromoléculaire, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Lydia Lartigue

    Department of Medical Oncology, Institut Bergonié, Institut National de la Santé et de la Recherche Medicale, Université Bordeaux Segalen, Bordeux, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Suzanne Vigneron

    Centre de Recherche de Biochimie Macromoléculaire, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Gilles Gadea

    Centre de Recherche de Biochimie Macromoléculaire, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Veronique Gire

    Centre de Recherche de Biochimie Macromoléculaire, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Maguy Del Rio

    Institut de Recherche en Cancérologie de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Isabelle Soubeyran

    Department of Medical Oncology, Institut Bergonié, Institut National de la Santé et de la Recherche Medicale, Université Bordeaux Segalen, Bordeaux, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Frederic Chibon

    Department of Medical Oncology, Institut Bergonié, Institut National de la Santé et de la Recherche Medicale, Université Bordeaux Segalen, Bordeaux, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Thierry Lorca

    Centre de Recherche de Biochimie Macromoléculaire, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Anna Castro

    Centre de Recherche de Biochimie Macromoléculaire, Université de Montpellier, Montpellier, France
    For correspondence
    anna.castro@crbm.cnrs.fr
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. James Ferrell, Stanford University, United States

Ethics

Animal experimentation: All animal experiments conformed to the relevant regulatory standards and were approved by the Ethics Local Committee of the IRCM (Institut de Recherche en Cancérologie de Montpellier) and by the Regional Ethic Commitée of the "Languedoc Roussillon"(France). Ref: 1137.

Human subjects: Human Samples for TMA:Cases were issued from the archives of the Department of Pathology of Bergonie Institute (Bordeaux, France). For all samples, ethical approval was obtained from the appropriate committees. Cases were then centralised in the Biological Resources Center of Bergonie Institute, which has received the agreement from the French authorities to deliver samples for scientific research (AC-2008-812)."The TMA used in this study has been moreover used in three other published studies (See: Soubeyran and al., Am J of Pathology 2011, Rey and al., Cell Cycle 2013 and Oncogene 2015).For colorectal tumour samples used for western blot:The study was approved by the ICM CORT (Translational Research Committee) ethical committee and all participating patients were informed of the study and provided their signed written informed consent before enrolment. This set of samples were already used in Del Rio et al., JCO 2007 and Del Rio et al, Plos one 2013.

Version history

  1. Received: July 15, 2015
  2. Accepted: November 26, 2015
  3. Accepted Manuscript published: November 27, 2015 (version 1)
  4. Version of Record published: January 18, 2016 (version 2)

Copyright

© 2015, Vera et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,704
    views
  • 458
    downloads
  • 42
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jorge Vera
  2. Lydia Lartigue
  3. Suzanne Vigneron
  4. Gilles Gadea
  5. Veronique Gire
  6. Maguy Del Rio
  7. Isabelle Soubeyran
  8. Frederic Chibon
  9. Thierry Lorca
  10. Anna Castro
(2015)
Greatwall promotes cell transformation by hyperactivating AKT in human malignancies
eLife 4:e10115.
https://doi.org/10.7554/eLife.10115

Share this article

https://doi.org/10.7554/eLife.10115

Further reading

    1. Cell Biology
    2. Developmental Biology
    Corey D Holman, Alexander P Sakers ... Patrick Seale
    Research Article

    The energy-burning capability of beige adipose tissue is a potential therapeutic tool for reducing obesity and metabolic disease, but this capacity is decreased by aging. Here, we evaluate the impact of aging on the profile and activity of adipocyte stem and progenitor cells (ASPCs) and adipocytes during the beiging process in mice. We found that aging increases the expression of Cd9 and other fibro-inflammatory genes in fibroblastic ASPCs and blocks their differentiation into beige adipocytes. Fibroblastic ASPC populations from young and aged mice were equally competent for beige differentiation in vitro, suggesting that environmental factors suppress adipogenesis in vivo. Examination of adipocytes by single nucleus RNA-sequencing identified compositional and transcriptional differences in adipocyte populations with aging and cold exposure. Notably, cold exposure induced an adipocyte population expressing high levels of de novo lipogenesis (DNL) genes, and this response was severely blunted in aged animals. We further identified Npr3, which encodes the natriuretic peptide clearance receptor, as a marker gene for a subset of white adipocytes and an aging-upregulated gene in adipocytes. In summary, this study indicates that aging blocks beige adipogenesis and dysregulates adipocyte responses to cold exposure and provides a resource for identifying cold and aging-regulated pathways in adipose tissue.

    1. Cell Biology
    Tongtong Ma, Ruimin Ren ... Heng Wang
    Research Article

    Current studies on cultured meat mainly focus on the muscle tissue reconstruction in vitro, but lack the formation of intramuscular fat, which is a crucial factor in determining taste, texture, and nutritional contents. Therefore, incorporating fat into cultured meat is of superior value. In this study, we employed the myogenic/lipogenic transdifferentiation of chicken fibroblasts in 3D to produce muscle mass and deposit fat into the same cells without the co-culture or mixture of different cells or fat substances. The immortalized chicken embryonic fibroblasts were implanted into the hydrogel scaffold, and the cell proliferation and myogenic transdifferentiation were conducted in 3D to produce the whole-cut meat mimics. Compared to 2D, cells grown in 3D matrix showed elevated myogenesis and collagen production. We further induced fat deposition in the transdifferentiated muscle cells and the triglyceride content could be manipulated to match and exceed the levels of chicken meat. The gene expression analysis indicated that both lineage-specific and multifunctional signalings could contribute to the generation of muscle/fat matrix. Overall, we were able to precisely modulate muscle, fat, and extracellular matrix contents according to balanced or specialized meat preferences. These findings provide new avenues for customized cultured meat production with desired intramuscular fat contents that can be tailored to meet the diverse demands of consumers.